CIK 0001557376
- Non-accelerated filer
- Smaller reporting company
Zeo ScientifiX, Inc.
Sign in to watch- Ticker
- ZEOX
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 474180540
- Phone
- +1 888-963-7881
- Business address
- 3321 COLLEGE AVENUE, SUITE 246, DAVIE, FL, 33314
- Former names
- Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc., BESPOKE TRICYCLES INC
- 4 Grant or award President acquired 10,000,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 3,000,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 10,000,000 shares (grant or award)
- 4 Grant or award Chief Science Officer acquired 15,000,000 shares (grant or award)
- 4 Open-market buy Director bought 1,000,000 shares
- 4 Open-market buy Director bought 1,000,000 shares
- 4 Grant or award Chief Financial Officer acquired 15,000,000 shares (grant or award)
- 4 Grant or award President acquired 15,000,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 15,000,000 shares (grant or award)
- 4 Open-market buy Director bought 625,000 shares at $0.08 ($50,000)
- 4 Grant or award Chief Science Officer acquired 15,000,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 15,000,000 shares (grant or award)
- 4 Grant or award President acquired 15,000,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 7,000,000 shares (grant or award)
- 4 Grant or award Chief Science Officer acquired 7,000,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 7,000,000 shares (grant or award)
- 4 Grant or award President acquired 7,000,000 shares (grant or award)
- 4 Open-market buy Director bought 5,000,000 shares at $0.02 ($100,000)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 15,000,000 shares (grant or award)
Page 8 of 10 · 197 filings